Health & Life Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018
November 08, 2018 at 01:18 pm EST
Share
Health & Life Co., Ltd. announced earnings results for the third quarter and nine months ended September 30, 2018. For the third quarter, the company announced sales was TWD 200.835 million compared to TWD 146.529 million a year ago. Operating loss was TWD 5.295 million compared to TWD 11.464 million a year ago. Net loss was TWD 5.961 million compared to TWD 8.372 million a year ago. Basic and diluted loss per share was TWD 0.12 compared to TWD 0.18 a year ago.
For the nine months, sales was TWD 506.462 million compared to TWD 401.335 million a year ago. Operating loss was TWD 43.281 million compared to TWD 46.012 million a year ago. Net loss was TWD 29.109 million compared to TWD 49.379 million a year ago. Basic and diluted loss per share was TWD 0.61 compared to TWD 1.04 a year ago.
Health & Life Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of medical equipment. The Company's mainly provides electronic sphygmomanometers, such as blood pressure monitors, nebulizers and blood glucose monitoring systems, which are used to measure and record systolic and diastolic blood pressure and glucose of human beings. The Company distributes its products within domestic market and to overseas markets.